The only advantage buying at these prices is to average down in the hope of the pump and dump which will inevitably happen at some point.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025